West Pharmaceutical Services WST Return on invested capital
Return on invested capital at other companies
Other financials
Where this comes from
Calculated from West Pharmaceutical Services’s reported figures.
Based on trailing twelve months.
The official record: West Pharmaceutical Services’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about West Pharmaceutical Services's return on invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is West Pharmaceutical Services's return on invested capital?
- West Pharmaceutical Services (WST) reported return on invested capital of 19.2% in Q1 2026.
- How has West Pharmaceutical Services's return on invested capital changed year-over-year?
- West Pharmaceutical Services's return on invested capital increased by 8.0% year-over-year, from 17.8% to 19.2%.
- What is the long-term trend for West Pharmaceutical Services's return on invested capital?
- Over 4 years (2021 to 2025), West Pharmaceutical Services's return on invested capital has grown at a -13.8% compound annual growth rate (CAGR), from 128.9% to 71.1%.
- What does return on invested capital mean?
- The after-tax return the business earns on all the capital — debt and equity — invested in it.
- How do you interpret return on invested capital?
- The cleanest measure of business quality: ROIC sustained above the cost of capital creates value, below it destroys value. Compare against WACC, not against zero.
- How does return on invested capital compare across companies?
- Highly comparable across companies as a quality screen. Sector-sensitive definitions of invested capital mean banks/insurers are best excluded.